Conceivable Life Sciences
Pioneering the world's first end-to-end automated IVF lab.
Pioneering the world's first end-to-end automated IVF lab.
Conceivable Life Sciences is a biotechnology startup that aims to revolutionize the world of in vitro fertilization (IVF). With a promise to increase the number of families assisted by IVF by 10 times, the company is driven by a bold vision to make fertility treatment more accessible and effective. Since its establishment in 2022, the company has garnered significant attention and support from prominent investors. In their latest funding round in August 2023, Conceivable Life Sciences secured an impressive $20.00M investment from a group of notable backers including Future Positive Capital, ACME Capital, Stride, and Karatage. With its headquarters in the United States, the company has set out to disrupt the IVF landscape and offer new hope to countless families worldwide.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | $20.00M | 4 |
|
01 Aug 2023 |
No recent news or press coverage available for Conceivable Life Sciences.
We care about your data, and we'd love to use cookies make your experience better.